Planet 13 Holdings (PLNH) Gains from Investment Securities (2021 - 2023)
Planet 13 Holdings' (PLNH) quarterly Gains from Investment Securities came in at -$18127.0 in Q1 2023, up 99.57% year-on-year from -$9082.8 in Q1 2022, and up 90.19% on a QoQ basis from -$184850.0 in Q4 2022.
Planet 13 Holdings (PLNH) Gains from Investment Securities (2021 - 2023) Analysis & Trends
Planet 13 Holdings (PLNH) has 3 years of Gains from Investment Securities data on file, last reported at -$18127.0 in Q1 2023.
- On a quarterly basis, Gains from Investment Securities rose 99.57% year-over-year to -$18127.0 in Q1 2023; TTM through Dec 2023 was -$18127.0, a 99.75% increase from a year earlier, with the FY2023 full-year figure at -$18127.0, up 99.75% from the prior year.
- Gains from Investment Securities for Q1 2023 stood at -$18127.0, up from -$184850.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for PLNH reached as high as $9.3 million in Q2 2021 and fell as low as -$6.5 million in Q3 2021.
- Historically, Gains from Investment Securities has averaged -$800383.6 across 3 years, with a median of -$197721.0 in 2022.
- Across the five-year window, Gains from Investment Securities plunged 29028.91% in 2022 and surged 99.57% in 2023, its largest moves.
- Year by year, Gains from Investment Securities stood at -$2.7 million in 2021, then jumped by 93.24% to -$184850.0 in 2022, then soared by 90.19% to -$18127.0 in 2023.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$18127.0 in Q1 2023, -$184850.0 in Q4 2022, and -$197721.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.42 Mn | 23.16 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -18,127.00 |
| Mar 31, 2023 | -18,127.00 |
| Dec 31, 2022 | -184,850.00 |
| Dec 31, 2022 | -184,850.00 |
| Sep 30, 2022 | -197,721.00 |
| Sep 30, 2022 | -197,721.00 |
| Jun 30, 2022 | -2.53 Mn |
| Jun 30, 2022 | -2.53 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Dec 31, 2021 | -2.74 Mn |
| Dec 31, 2021 | -2.74 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Jun 30, 2021 | 9.27 Mn |
| Jun 30, 2021 | 9.27 Mn |
| Mar 31, 2021 | -14,641.00 |
| Mar 31, 2021 | -14,641.00 |